Indeed, mice genetically deficient in PPARγ develop insulin resistance [172] and PPAR agonists such as rosiglitazone and pioglitazone are widely used in the treatment of type 2 diabetes [173]. The gene discussed is PPARA; the disease is Insulin resistance.